John P Murtha Neuroscience and Pain Institute
Johnstown, Pennsylvania, 15904, United States
NCT Number: NCT00714727
The object of this research study is to test a standardized set of acupuncture points on migraine patients to reduce frequency and intensity of headaches. Acupuncture has been studied in prior research but the treatment points have varied between subjects, making it difficult to replicate studies.
Looking for future studies?
Notify Me21 year–65 year
All sexes
Interventional
Phase 1
Johnstown, Pennsylvania, 15904, United States
Subjects will be recording daily headache activity on personal digital assistants (PDA's) for 12 weeks before and 12 weeks after 8 weeks of acupuncture intervention. MIDAS, HIT-6 and BDI-II measurements will be done at the beginning of the study (12 weeks pre-intervention), directly before the intervention, directly after, and 12 weeks post-intervention. Measurements will be compared before and after intervention. This is a follow-up to a successful earlier study when these same acupuncture points were used on subjects with chronic daily headache, the majority being migraine.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
8 weeks of acupuncture, starting with twice a week for 4 weeks, followed by once a week for 4 weeks, using 8 standardized, bilateral acupuncture points.
Other names: Migraines
Time frame: 32 weeks
Time frame: 32 weeks
Memorial Medical Center
Other
Acronym: SPAMDA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01706003
Brain Diseases, Central Nervous System Diseases
Dallas, Texas, United States
View Trial DetailsNCT00109083
Brain Diseases, Central Nervous System Diseases
Northport, Alabama, United States
View Trial DetailsNCT05536635
Brain Diseases, Breathing Techniques
Izmir, Turkey (Türkiye)
View Trial DetailsNCT02351544
Brain Diseases, Central Nervous System Diseases
San Francisco, California, United States
View Trial Details